Questa Capital, a healthcare venture capital, led the $20m Series B round in Free Market Health, a software company, with participation from Alta Partners, Highmark Ventures, and 653 Investment Partners. "The specialty pharma industry is at a tipping point, and payers are seeking more control over how they manage their specialty pharmacy programs. We believe Free Market Health is a proven platform that adds significant value through price transparency, access, and individualized care. We are excited to partner with this experienced team and their solution which benefits everyone in the specialty pharmacy ecosystem, including and most importantly the patient managing serious and/or chronic disease," Ryan Drant, Questa Capital Founder and Managing Partner.